Goldan Keith A.
Insider CIK 1495411 · PATH CFO and VP · SNDX Chief Financial Officer · OPTN Chief Financial Officer · ABEO Director · FCSC SVP and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2026-06-01 | 2026-06-02 | 1,177 | $18.99 | $22.4K | 139,252 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2026-04-01 | 2026-04-07 | 32,751 | — | $0 | 32,751 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2026-02-09 | 2026-02-10 | 3,410 | $21.03 | $71.7K | 140,429 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2026-02-06 | 2026-02-06 | 2,082 | $20.62 | $42.9K | 143,839 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2026-02-04 | 2026-02-06 | 118,000 | $20.43 | $2.41M | 118,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2026-02-04 | 2026-02-06 | 21,500 | — | $0 | 115,171 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2026-02-04 | 2026-02-06 | 30,750 | — | $0 | 145,921 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2026-01-30 | 2026-02-06 | 1,219 | $8.48 | $10.3K | 93,671 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | G Gift | 2025-12-01 | 2025-12-01 | 1,224 | — | $0 | 92,452 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2025-07-31 | 2025-08-07 | 1,226 | $8.43 | $10.3K | 93,676 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2025-07-16 | 2025-07-18 | 1,296 | $9.29 | $12.0K | 92,450 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2025-05-19 | 2025-05-19 | 3,000 | — | $0 | 93,746 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2025-02-10 | 2025-02-12 | 3,777 | $15.50 | $58.5K | 90,746 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2025-02-05 | 2025-02-07 | 110,500 | $14.65 | $1.62M | 110,500 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2025-02-05 | 2025-02-07 | 23,400 | — | $0 | 94,523 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2025-02-05 | 2025-02-07 | 18,500 | — | $0 | 71,123 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2024-06-14 | 2024-06-17 | 1,250 | $20.03 | $25.0K | 52,623 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2024-02-07 | 2024-02-09 | 70,000 | $22.28 | $1.56M | 70,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2024-02-07 | 2024-02-09 | 35,000 | — | $0 | 39,673 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2024-02-07 | 2024-02-09 | 11,700 | — | $0 | 51,373 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2024-01-31 | 2024-02-09 | 1,183 | $17.42 | $20.6K | 4,673 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2023-07-31 | 2024-02-09 | 862 | $18.12 | $15.6K | 3,490 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-06-13 | 2023-06-14 | 577 | $22.31 | $12.9K | 2,628 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2023-02-02 | 2023-02-03 | 110,000 | $28.55 | $3.14M | 110,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2022-06-13 | 2022-06-15 | 230,000 | $15.60 | $3.59M | 230,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2022-06-13 | 2022-06-15 | 3,205 | — | $0 | 3,205 | SEC↗ |
| OPTN OptiNose, Inc. | S Sale | 2022-03-16 | 2022-03-17 | 4,617 | $2.11 | $9.7K | 141,726 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2022-01-11 | 2022-01-12 | 66,185 | — | $0 | 66,185 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2022-01-11 | 2022-01-12 | 85,095 | — | $0 | 85,095 | SEC↗ |
| OPTN OptiNose, Inc. | A Award | 2022-01-11 | 2022-01-12 | 56,730 | — | $0 | 146,343 | SEC↗ |
| OPTN OptiNose, Inc. | S Sale | 2021-12-16 | 2021-12-17 | 580 | $1.64 | $951 | 89,613 | SEC↗ |
| OPTN OptiNose, Inc. | S Sale | 2021-09-16 | 2021-09-17 | 578 | $2.79 | $1.6K | 90,193 | SEC↗ |
| OPTN OptiNose, Inc. | S Sale | 2021-06-17 | 2021-06-17 | 576 | $3.73 | $2.1K | 90,771 | SEC↗ |
| OPTN OptiNose, Inc. | S Sale | 2021-03-15 | 2021-03-17 | 2,304 | $3.92 | $9.0K | 91,347 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 80,000 | $3.51 | $280.8K | 80,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award | 2021-03-04 | 2021-03-08 | 53,333 | — | $0 | 63,084 | SEC↗ |
| OPTN OptiNose, Inc. | P Buy | 2020-09-23 | 2020-09-23 | 2,500 | $3.90 | $9.8K | 9,751 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-03-06 | 2021-03-17 | 45,850 | $5.41 | $248.0K | 45,850 | SEC↗ |
| OPTN OptiNose, Inc. | A Award | 2020-03-06 | 2021-03-17 | 30,567 | — | $0 | 37,328 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-03-06 | 2020-03-09 | 45,850 | $5.41 | $248.0K | 45,850 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-03-06 | 2020-03-09 | 30,567 | — | $0 | 30,567 | SEC↗ |
| OPTN OptiNose, Inc. | A Award | 2019-06-28 | 2019-07-09 | 941 | $5.64 | $5.3K | 4,066 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2019-02-28 | 2019-03-06 | 82,500 | — | $0 | 82,500 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2017-10-12 | 2017-10-16 | 72,197 | — | $0 | 72,197 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2016-03-01 | 2016-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| FCSC Fibrocell Science, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 2,000 | $6.33 | $12.7K | 2,000 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 99,704 | $4.88 | $486.6K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer | 2014-02-21 | 2014-02-25 | 147,191 | $6.80 | $1.00M | 0 | SEC↗ |
| PATH NUPATHE INC. | U Tender | 2014-02-21 | 2014-02-25 | 18,875 | $6.80 | $128.3K | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-17 | 2013-01-22 | 125,000 | — | $0 | 166,066 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2013-01-07 | 2013-01-09 | 16,219 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2013-01-07 | 2013-01-09 | 39,300 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-07 | 2013-01-09 | 28,165 | — | $0 | 41,066 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-07 | 2013-01-09 | 8,109 | — | $0 | 12,901 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-03-08 | 2012-03-27 | 39,300 | — | $0 | 39,300 | SEC↗ |